comparemela.com

Latest Breaking News On - Springworks careconnections - Page 1 : comparemela.com

FDA Approves Ogsiveo for Adults With Desmoid Tumors

SpringWorks Therapeutics Announces FDA Approval of OGSIVEO (nirogacestat) as the First and Only Treatment for Adults with Desmoid Tumors

28.11.2023 - – Approval based on positive data from Phase 3 DeFi trial, in which OGSIVEO significantly improved progression-free survival and objective response rate, with rapid and sustained improvements in pain, physical functioning and overall quality of life .

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.